Stem Holdings, Inc. (STMH)

Overall impact
D (32)

Commentary

Stem Holdings, Inc. is a below-average overall performer. With a 'D' rating of 31.8 for overall impact (bottom 25% of all companies), Stem Holdings, Inc. ranks 241st out of 244 industry peers, behind Catalyst Pharmaceuticals, Agios Pharmaceuticals, Pharmaron Beijing H and 237 others, and ahead of Amneal Pharmaceuticals, Endo International, and Curaleaf. On top material causes for Stem Holdings, Inc.'s industry (Pharmaceuticals), Stem Holdings, Inc. performs poorly in Sustainable Use of Water (25.1 score), Access to Affordable Healthcare (21.8), Reduced Waste (39.8) and 54 other causes where it received a 'D' or 'F' score. Stem Holdings, Inc. did not receive an 'A' rating on any cause.
Impact
Cause STMH
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
75
Sector
Health Care
Industry
Pharmaceuticals
Sub-industry
Pharmaceuticals
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Fl, United States
Share classes
STMH
Description
Stem Holdings, Inc. does not have significant operations. Previously, the company operated as a vertically-integrated cannabis products and technology company. Its brands include TJ's Gardens, TravisxJames, and Yerba Buena flower and extracts; Cannavor edible confections; and e-commerce delivery platforms provided direct-to consumer proprietary logistics and an omnichannel UX (user experience)/CX (customer experience). The company was incorporated in 2016 and is headquartered in Boca Raton, Florida.
Material causes
Ethos considers the following causes material for Stem Holdings, Inc., based on its industry sub-industry Pharmaceuticals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.